Evidence map›Paper›PMID 30585174›Full record

ArticleAging2018

Hyperoside attenuates renal aging and injury induced by D-galactose via inhibiting AMPK-ULK1 signaling-mediated autophagy.

Buhui Liu, Yue Tu, Weiming He, Yinglu Liu, Wei Wu, Qijun Fang, Haitao Tang, Renmao Tang, Ziyue Wan, Wei Sun and 1 more

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Aging, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 74 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Hyperoside, a flavonoid, inducesScience advances · 2025
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Buhui Liu *Department of Traditional Chinese Medicine, Nanjing Drum Tower Hospital Clinical College of Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing 210008, China.
Yue Tu *Department of TCM Health Preservation, Second Clinic Medical School, Nanjing University of Chinese Medicine, Nanjing 210023, China.
Weiming HeDepartment of Nephrology, The Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing 210029, China.
Yinglu LiuDepartment of Traditional Chinese Medicine, Nanjing Drum Tower Hospital Clinical College of Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing 210008, China.
Wei WuDepartment of Traditional Chinese Medicine, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing 210008, China.
Qijun FangDepartment of Traditional Chinese Medicine, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing 210008, China.
Haitao TangInstitute of Huangkui, Suzhong Pharmaceutical Group Co., Ltd., Taizhou 225500, China.
Renmao TangInstitute of Huangkui, Suzhong Pharmaceutical Group Co., Ltd., Taizhou 225500, China.
Ziyue WanDepartment of Social Work, Meiji Gakuin University, Tokyo 108-8636, Japan.
Wei SunDepartment of Nephrology, The Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing 210029, China.
Yigang WanDepartment of Traditional Chinese Medicine, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing 210008, China.
Nanjing Drum Tower Hospital · CNNanjing University of Chinese Medicine · CNMeiji Gakuin University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The kidney is a typical organ undergoing age and injury. Hyperoside is reported to be useful for preventing aging induced by D-galactose (D-gal). However, therapeutic mechanisms remain unclear. We thereby aimed to verify whether hyperoside, compared to vitamin E (VE), could alleviate renal aging and injury by regulating autophagic activity and its related signaling pathways.

Indexed as

AnimalsAutophagyAutophagy-Related Protein-1 HomologGalactoseGene Expression RegulationKidneyKidney DiseasesMaleProtein KinasesQuercetinRatsRats, Sprague-DawleySignal TransductionAutophagy-Related Protein-1 HomologGalactosehyperosideProtein KinasesQuercetinULK1 protein, ratAMPK-ULK1 signaling pathwayautophagyhyperosidemTOR signaling pathwayrenal agingvitamin E

Identifiers

PMID30585174
PMCPMC6326678
OpenAlexW2906389384

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.